DINMAG

Maryland and the District of Columbia are part of a multistate lawsuit seeking to block a federal rule that would stop states from claiming federal Medicaid and Children’s Health Insurance Program money for specified gender-affirming care provided to minors and some young adults.

The rule is scheduled to take effect Oct. 13. That date gives the case immediate importance for transgender young people, families, clinicians and safety-net providers across Baltimore and Washington. It also makes careful wording essential: the rule concerns federal reimbursement. It is not, by itself, a nationwide criminal ban on care, and it does not mean every existing appointment or prescription has already ended.

What the federal rule would do

The Centers for Medicare and Medicaid Services says the final rule bars federal Medicaid funding for covered interventions provided to patients under 18 and applies a similar CHIP restriction to patients under 19. CMS says mental-health services remain covered. For people already receiving hormone therapy, the agency allows states to claim federal matching funds during a tapering period of up to six months after the effective date.

The administration describes the affected treatment in sharply contested terms and argues the rule protects young people. Major medical groups and state officials challenging the policy describe the services as medically necessary gender-affirming care selected through individualized clinical decision-making. Readers should understand that the fight is both legal and medical, and that the two sides do not agree on the evidence or the federal government’s authority.

What Maryland and DC are arguing

The Sept. 2 complaint, filed in federal court in Massachusetts, includes Maryland, the District and 20 other plaintiff jurisdictions. The coalition alleges that the Department of Health and Human Services and CMS exceeded their statutory authority, violated the Administrative Procedure Act and intruded on states’ administration of Medicaid and CHIP.

Maryland Attorney General Anthony Brown’s office says Congress has historically given states room to decide which medically necessary services their programs cover, subject to federal law. The federal government disputes that position. Briefing in the case is ongoing, according to Georgetown Law’s Health Care Litigation Tracker.

What local families should know now

Maryland’s Medicaid website says there is currently no change to gender-affirming coverage and advises residents to watch for updates. Maryland Health Connection likewise says members will receive an official notice before coverage changes. Because the litigation is unresolved and plan administration can vary, families should not rely on a social post or assume a denial before receiving plan-specific information.

A practical checklist is straightforward: keep scheduled appointments unless a provider says otherwise, save every written notice from Medicaid or a managed-care plan, ask whether any authorization deadline is approaching, and request appeal information if coverage is denied. District residents should also watch DC Medicaid and the Office of the Attorney General for implementation guidance.

The legal question may take time. The coverage question will arrive much sooner. For local readers, the safest conclusion on Sept. 24 is that Maryland and DC are fighting the rule, the federal effective date remains Oct. 13, and current Maryland guidance says coverage has not yet changed.